P
Palvella Therapeutics, Inc.
PVLA · NASDAQ · Healthcare · 2.2B
Closing price
$138.77
+5.66% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
55.8×
Enterprise value / EBITDAEV/EBITDA
-41.9×
Free cash flow yieldFCF yield
-1.6%
Return on equityROE
-149.1%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.6×
Interest coverage
-6.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.